Ranitidine Hydrochloride + Domperidone
Composition
Ranitidine Hydrochloride and Domperidone tablets contain the active ingredients ranitidine hydrochloride and domperidone, combined with excipients like microcrystalline cellulose, magnesium stearate, and lactose. These components ensure drug stability, effective absorption, and proper tablet formulation.
Indications
Ranitidine Hydrochloride and Domperidone tablets are indicated for the treatment of gastroesophageal reflux disease (GERD), peptic ulcers, and conditions requiring reduction of stomach acid and increased gastrointestinal motility.
Side effects
Common side effects include headache, dizziness, constipation, and diarrhea; serious side effects can include cardiac arrhythmias and severe allergic reactions.
Precautions
Use with caution in patients with renal or hepatic impairment, and monitor for signs of gastrointestinal bleeding or severe allergic reactions.
Contraindications
Contraindicated in patients with known hypersensitivity to ranitidine, domperidone, or any of the tablet's excipients, and in those with prolactinoma or gastrointestinal perforation.
Dosage and administration
Typically administered as one tablet twice daily before meals, but dosage may be adjusted based on the severity of the condition and patient response. Always follow the prescribing physician's instructions.
Countries
India, USA, UK
Available Forms
Tablets, capsules
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai